Clinical Trial Update: Value of Prothrombin Fragment F1+2 in the Diagnosis of Pulmonary Embolism in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbation

View source ↗

Summary

A clinical trial evaluating whether measuring prothrombin fragment F1+2 improves diagnosis of pulmonary embolism in patients with COPD exacerbation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Embolism

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Chronic Obstructive Pulmonary Disease, Pulmonary Embolism | Status: UNKNOWN